Vitasora Health Limited (ASX:VHL)

Australia flag Australia · Delayed Price · Currency is AUD
0.0140
+0.0020 (16.67%)
May 6, 2026, 3:49 PM AEST
Market Cap27.15M -49.3%
Revenue (ttm)5.01M +170.3%
Net Income-11.59M
EPS-0.01
Shares Out1.94B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume133,460
Average Volume798,734
Open0.0120
Previous Close0.0120
Day's Range0.0120 - 0.0140
52-Week Range0.0120 - 0.0470
Beta-0.31
RSI33.52
Earnings DateMay 27, 2026

About Vitasora Health

Vitasora Health Limited researches, develops, and commercializes medical devices in Australia and the United States. It is also involved in the production of mobile health applications. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia. [Read more]

Sector Healthcare
Founded 1987
Employees 30
Stock Exchange Australian Securities Exchange
Ticker Symbol VHL
Full Company Profile

Financial Performance

In fiscal year 2025, Vitasora Health's revenue was 3.71 million, an increase of 256.78% compared to the previous year's 1.04 million. Losses were -10.11 million, 41.7% more than in 2024.

Financial Statements

News

Vitasora Health Transcript: Status update

Revenue and billing rates are rising sharply, driven by regulatory tailwinds, dual enrollment growth, and automation. A new AI-enabled EMR system launches April 1, expected to boost efficiency and cash flow, with breakeven targeted by mid-year.

6 weeks ago - Transcripts

Vitasora Health Transcript: Status Update

Significant U.S. growth is driven by value-based contracts, a scalable turnkey platform, and strong client satisfaction. Revenue is projected to triple next year, with a shift toward risk-sharing models and major new contracts in the pipeline. Expansion is supported by regulatory tailwinds and a focus on large strategic partners.

1 year ago - Transcripts